Literature DB >> 3487084

Interaction between a "processed" ovalbumin peptide and Ia molecules.

S Buus, S Colon, C Smith, J H Freed, C Miles, H M Grey.   

Abstract

The binding of 125I-labeled immunogenic peptides to purified Ia molecules in detergent solution was examined by equilibrium dialysis. We used the chicken ovalbumin peptide ovalbumin-(323-339)-Tyr, which is immunogenic in the BALB/c mouse and restricted to I-Ad. 125I-labeled ovalbumin-(323-339)-Tyr was shown to bind to I-Ad but not to I-Ed, I-Ek, or I-Ak. This binding was inhibited by unlabeled ovalbumin-(323-339) but not by ovalbumin-(329-339), which is the longest N-terminally truncated peptide that fails to stimulate any of the I-Ad-restricted hybridomas that have been raised to ovalbumin-(323-339)-Tyr. As a further specificity control, we also used the chicken egg lysozyme peptide Tyr-(46-61), which has recently been studied by similar methods [Babbitt, B. P., Allen, P. M., Matsueda, G., Haber, E. & Unanue, E. R. (1985) Nature (London) 317, 359-361]. We have confirmed that it bound to I-Ak but not to I-Ek, I-Ad, or I-Ed. Thus, a specific interaction between Ia and antigen that correlates with the major histocompatibility complex restriction was demonstrated, strongly arguing in favor of a determinant selection hypothesis for such restriction.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3487084      PMCID: PMC323646          DOI: 10.1073/pnas.83.11.3968

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

Review 1.  A hypothesis to relate the specificity of T lymphocytes and the activity of I region-specific Ir genes in macrophages and B lymphocytes.

Authors:  B Benacerraf
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

2.  Synthesis of the antibacterial peptide cecropin A (1-33).

Authors:  R B Merrifield; L D Vizioli; H G Boman
Journal:  Biochemistry       Date:  1982-09-28       Impact factor: 3.162

Review 3.  Determinant selection and macrophage function in genetic control of the immune response.

Authors:  A S Rosenthal
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

4.  Chemically related antigens compete for presentation by accessory cells to T cells.

Authors:  O Werdelin
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

5.  The Ia molecule of the antigen-presenting cell plays a critical role in immune response gene regulation of T cell activation.

Authors:  E Heber-Katz; D Hansburg; R H Schwartz
Journal:  J Mol Cell Immunol       Date:  1983

6.  Generation of T cell colonies from responder strain 2 guinea pigs that recognize the copolymer L-glutamic acid, L-lysine in association with nonresponder strain 13 Ia antigens.

Authors:  R B Clark; E M Shevach
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307

7.  Responder T cells depleted of alloreactive cells react to antigen presented on allogeneic macrophages from nonresponder strains.

Authors:  N Ishii; C N Baxevanis; Z A Nagy; J Klein
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

8.  Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes.

Authors:  A S Rosenthal; E M Shevach
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

9.  Inhibition of antigen-specific T lymphocyte activation by structurally related Ir gene-controlled polymers. Evidence of specific competition for accessory cell antigen presentation.

Authors:  K L Rock; B Benacerraf
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

10.  Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition.

Authors:  J W Kappler; B Skidmore; J White; P Marrack
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  63 in total

1.  The kinetic basis of peptide exchange catalysis by HLA-DM.

Authors:  J A Zarutskie; R Busch; Z Zavala-Ruiz; M Rushe; E D Mellins; L J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

2.  Parasite-specific T-cell responses of trypanotolerant and trypanosusceptible cattle during infection with Trypanosoma congolense.

Authors:  J N Flynn; M Sileghem; D J Williams
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

Review 3.  T cells causing immunological disease.

Authors:  R M Zinkernagel; H Pircher; P S Ohashi; H Hengartner
Journal:  Springer Semin Immunopathol       Date:  1992

4.  Kinetics of antigenic peptide binding to the class II major histocompatibility molecule I-Ad.

Authors:  R Tampé; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

5.  Point mutations define positions in HLA-DR3 molecules that affect antigen presentation.

Authors:  E Mellins; B Arp; D Singh; B Carreno; L Smith; A H Johnson; D Pious
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

6.  Modulation of T cell responses with MHC-derived peptides.

Authors:  W V Williams; D B Weiner; M A Borofsky; D H Rubin; K Yui; M I Greene
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

Review 7.  Mapping T cell receptor epitopes on the A beta polypeptide.

Authors:  B N Beck; D J McKean
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

8.  Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice.

Authors:  W Gerhard; A M Haberman; P A Scherle; A H Taylor; G Palladino; A J Caton
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

Review 9.  Discovering protective CD8 T cell epitopes--no single immunologic property predicts it!

Authors:  Pavlo Gilchuk; Timothy M Hill; John T Wilson; Sebastian Joyce
Journal:  Curr Opin Immunol       Date:  2015-02-06       Impact factor: 7.486

10.  Processing and presentation of tetanus toxin by antigen-presenting cells from patients with chronic granulomatous disease (CGD) to human specific T cell clones are not impaired.

Authors:  C Barbey; J M Tiercy; N Fairweather; H Niemann; R Seger; G Corradin
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.